Cargando…

Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study

Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding cardiovascular disease (CVD). Our objective was to examine how levels and trajectories of metabolic risk factors and biochemical markers prior to diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulsegge, Gerben, Spijkerman, Annemieke M. W., van der Schouw, Yvonne T., Bakker, Stephan J. L., Gansevoort, Ron T., Smit, Henriette A., Verschuren, W. M. Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874669/
https://www.ncbi.nlm.nih.gov/pubmed/27203599
http://dx.doi.org/10.1371/journal.pone.0155978
_version_ 1782433072243802112
author Hulsegge, Gerben
Spijkerman, Annemieke M. W.
van der Schouw, Yvonne T.
Bakker, Stephan J. L.
Gansevoort, Ron T.
Smit, Henriette A.
Verschuren, W. M. Monique
author_facet Hulsegge, Gerben
Spijkerman, Annemieke M. W.
van der Schouw, Yvonne T.
Bakker, Stephan J. L.
Gansevoort, Ron T.
Smit, Henriette A.
Verschuren, W. M. Monique
author_sort Hulsegge, Gerben
collection PubMed
description Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding cardiovascular disease (CVD). Our objective was to examine how levels and trajectories of metabolic risk factors and biochemical markers prior to diagnosis differ between people with and without CVD over a period of up to 15–20 years. A total of 449 incident non-fatal and fatal CVD cases and 1,347 age- and sex-matched controls were identified in a prospective cohort between 1993 and 2011. Metabolic risk factors and biochemical markers were measured at five-year intervals prior to diagnosis. Trajectories of metabolic risk factors and biochemical markers were analysed using random coefficient analyses. Although not always statistically significant, participants with CVD had slightly more unfavourable levels for most metabolic risk factors and biochemical markers 15–20 years before diagnosis than controls. Subsequent trajectories until diagnosis were similar in participants with incident CVD and controls for body mass index, diastolic blood pressure, total cholesterol, HDL cholesterol, random glucose, triglycerides, gamma glutamyltransferase, C-reactive protein and uric acid. Trajectories were more unfavourable in participants with CVD than controls for systolic blood pressure, waist circumference and estimated glomerular filtration rate (p≤0.05). For example, among participants with CVD, systolic blood pressure increased on average by 9 mmHg over the 18-year period preceding diagnosis, whereas the increase among controls was 4 mmHg. In conclusion, unfavourable levels of metabolic risk factors and biochemical markers are present long before CVD, which indicates that the risk of CVD is already partly determined in young adulthood. This underscores the need for early prevention to reduce the burden of CVD.
format Online
Article
Text
id pubmed-4874669
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48746692016-06-09 Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study Hulsegge, Gerben Spijkerman, Annemieke M. W. van der Schouw, Yvonne T. Bakker, Stephan J. L. Gansevoort, Ron T. Smit, Henriette A. Verschuren, W. M. Monique PLoS One Research Article Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding cardiovascular disease (CVD). Our objective was to examine how levels and trajectories of metabolic risk factors and biochemical markers prior to diagnosis differ between people with and without CVD over a period of up to 15–20 years. A total of 449 incident non-fatal and fatal CVD cases and 1,347 age- and sex-matched controls were identified in a prospective cohort between 1993 and 2011. Metabolic risk factors and biochemical markers were measured at five-year intervals prior to diagnosis. Trajectories of metabolic risk factors and biochemical markers were analysed using random coefficient analyses. Although not always statistically significant, participants with CVD had slightly more unfavourable levels for most metabolic risk factors and biochemical markers 15–20 years before diagnosis than controls. Subsequent trajectories until diagnosis were similar in participants with incident CVD and controls for body mass index, diastolic blood pressure, total cholesterol, HDL cholesterol, random glucose, triglycerides, gamma glutamyltransferase, C-reactive protein and uric acid. Trajectories were more unfavourable in participants with CVD than controls for systolic blood pressure, waist circumference and estimated glomerular filtration rate (p≤0.05). For example, among participants with CVD, systolic blood pressure increased on average by 9 mmHg over the 18-year period preceding diagnosis, whereas the increase among controls was 4 mmHg. In conclusion, unfavourable levels of metabolic risk factors and biochemical markers are present long before CVD, which indicates that the risk of CVD is already partly determined in young adulthood. This underscores the need for early prevention to reduce the burden of CVD. Public Library of Science 2016-05-20 /pmc/articles/PMC4874669/ /pubmed/27203599 http://dx.doi.org/10.1371/journal.pone.0155978 Text en © 2016 Hulsegge et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hulsegge, Gerben
Spijkerman, Annemieke M. W.
van der Schouw, Yvonne T.
Bakker, Stephan J. L.
Gansevoort, Ron T.
Smit, Henriette A.
Verschuren, W. M. Monique
Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title_full Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title_fullStr Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title_full_unstemmed Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title_short Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease – The Doetinchem Cohort Study
title_sort trajectories of metabolic risk factors and biochemical markers prior to the onset of cardiovascular disease – the doetinchem cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874669/
https://www.ncbi.nlm.nih.gov/pubmed/27203599
http://dx.doi.org/10.1371/journal.pone.0155978
work_keys_str_mv AT hulseggegerben trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT spijkermanannemiekemw trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT vanderschouwyvonnet trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT bakkerstephanjl trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT gansevoortront trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT smithenriettea trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy
AT verschurenwmmonique trajectoriesofmetabolicriskfactorsandbiochemicalmarkerspriortotheonsetofcardiovasculardiseasethedoetinchemcohortstudy